A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

January 31, 2027

Conditions
Solid Tumor, Adult
Interventions
DRUG

KQB198

Oral KQB198

DRUG

osimertinib

Oral osimertinib

Trial Locations (34)

10408

RECRUITING

National Cancer Center, Goyang-si

11101

RECRUITING

David H. Koch Center for Cancer Center at Memorial Sloan Kettering Cancer Center, Long Island City

11217

RECRUITING

Taipei Veterans General Hospital, Taipei

13009

RECRUITING

Institut Paoli-Calmettes, Marseille

22031

RECRUITING

New Experimental Therapeutics of Virginia - NEXT Oncology, Fairfax

28034

RECRUITING

Hospital Universitario Ramon y Cajal, Madrid

28040

RECRUITING

South Texas Accelerated Research Therapeutics (START) Madrid - CIOCC, Madrid

28223

RECRUITING

New Experimental Therapeutics (NEXT) Oncology Madrid - Hospital Quironsalud Madrid, Madrid

29004

RECRUITING

Hospital Quirónsalud Málaga, Málaga

31008

RECRUITING

Clinica Universidad de Navarra - Pamplona, Pamplona

31059

RECRUITING

IUCT-Oncopole, Toulouse

32827

RECRUITING

Sarah Cannon Research Institute at Florida Cancer Specialists - Lake Nona -, Orlando

33000

RECRUITING

CHU Bordeaux - Hopital Saint-Andre, Bordeaux

34232

RECRUITING

Florida Cancer Specialists - Sarasota, Sarasota

37203

RECRUITING

Sarah Cannon and HCA Research Institute, Nashville

40705

RECRUITING

Taichung Veterans General Hospital, Taichung

44000

RECRUITING

CHU de Nantes - Hopital Nord Laennec, Nantes

44800

RECRUITING

Institut de Cancerologie de l'Ouest - site St-Herblain, Saint-Herblain

45219

RECRUITING

The Lindner Center for Research and Education at The Christ Hospital, Cincinnati

48202

RECRUITING

Henry Ford Health System, Detroit

58128

RECRUITING

Chonnam National University Hwasun Hospital, Hwasun

73657

RECRUITING

Chi-Mei Hospital - Liouying Branch, Liuying

77030

RECRUITING

MD Anderson Cancer Center, Houston

78229

RECRUITING

New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio

80131

RECRUITING

"Istituto Nazionale Tumori IRCCS Fondazione G. Pascale", Napoli

80218

RECRUITING

Sarah Cannon Research Institute at HealthONE, Denver

100225

RECRUITING

National Taiwan University Hospital, Taipei

00168

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Rome

03722

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

06591

RECRUITING

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul

08028

RECRUITING

Hospital Universitari Quiron Dexeus Barcelona, Barcelona

08023

RECRUITING

New Experimental Therapeutics (NEXT) Oncology Barcelona, Barcelona

RECRUITING

South Texas Accelerated Research Therapeutics (START) Barcelona- HM Nou Delfos, Barcelona

Unknown

RECRUITING

South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid

Sponsors
All Listed Sponsors
lead

Kumquat Biosciences Inc.

INDUSTRY

NCT06507306 - A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies | Biotech Hunter | Biotech Hunter